Andreas Charalambous: New Lancet Commission for Lung Cancer
Andreas Charalambous, Chair of Nursing at University of Cyprus and Executive Board Member at The Multinational Association of Supportive Care in Cancer (MASCC), former President of the European Cancer Organization, Director of the e-OncoRise Research Center for Oncology and Palliative Care, shared a post on LinkedIn:
“NEW Lancet Commission on Lung Cancer
I am honored to announce that I will be one of the commissioners for the newly announced Lancet Commission on Lung Cancer – IALSC!
Through its commission program, The Lancet Group collaborates with leading academic institutions and global experts to investigate the most urgent and complex challenges in science, medicine, and public health. These commissions are designed to produce authoritative, evidence-based recommendations that influence health policy, guide clinical practice, and drive meaningful improvements in health outcomes worldwide.”
Get involved in the Lancet Commission.
More posts featuring Andreas Charalambous on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023